Pharmacogenomics of nicotine dependence and impact on smoking cessation

Journal article

Pharmacogenomic research into smoking behaviour and smoking cessation holds promise for understanding why people smoke and how we can better help people to quit. As smoking prevalence declines in thp United States and Western Europe through social and clinical action, average level of tobacco and nicotine-dependence amongst smokers may increase. The place of the pharmacogenomic contribution to understanding residual dependence and how to further lower smoking prevalence may increasingly come ...

Expand abstract

Authors: Johnstone, E; Murphy, M

• Journal: Current Pharmacogenomics
• Volume: 5
• Issue: 3
• Pages: 178-189
• Publication date: 2007-09-01
• DOI: 10.2174/157016007781669204
• ISSN: 1570-1603
• Language: English
• Keywords: CYP2A6; CCK gene; 5HT2A; Polymorphism; GABA; Smoking Cessation Clinical Trials